de State Street Agios Pharmaceuticals AGIO Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 131 M | Comprar |
3,533,633
+168,754
| +5% | +USD 5.12 M | ﹤0.01% | 1324 |
|
|
2026
Q1 | USD 114 M | Comprar |
3,364,879
+256,734
| +8% | +USD 7.28 M | ﹤0.01% | 1305 |
|
|
2025
Q4 | USD 84.6 M | Comprar |
3,108,145
+845,433
| +37% | +USD 29.7 M | ﹤0.01% | 1453 |
|
|
2025
Q3 | USD 90.8 M | Comprar |
2,262,712
+311,599
| +16% | +USD 11.7 M | ﹤0.01% | 1383 |
|
|
2025
Q2 | USD 64.9 M | Vender |
1,951,113
-498,366
| -20% | -USD 15.1 M | ﹤0.01% | 1540 |
|
|
2025
Q1 | USD 71.8 M | Comprar |
2,449,479
+297,202
| +14% | +USD 9.9 M | ﹤0.01% | 1449 |
|
|
2024
Q4 | USD 70.7 M | Vender |
2,152,277
-179,156
| -8% | -USD 8.42 M | ﹤0.01% | 1544 |
|
|
2024
Q3 | USD 104 M | Comprar |
2,331,433
+216,484
| +10% | +USD 9.8 M | ﹤0.01% | 1308 |
|
|
2024
Q2 | USD 91.2 M | Vender |
2,114,949
-1,023,248
| -33% | -USD 36.9 M | ﹤0.01% | 1322 |
|
|
2024
Q1 | USD 91.8 M | Comprar |
3,138,197
+512,512
| +20% | +USD 13.7 M | ﹤0.01% | 1367 |
|
|
2023
Q4 | USD 58.5 M | Comprar |
2,625,685
+361,851
| +16% | +USD 8.11 M | ﹤0.01% | 1622 |
|
|
2023
Q3 | USD 56 M | Vender |
2,263,834
-317,635
| -12% | -USD 8.4 M | ﹤0.01% | 1561 |
|
|
2023
Q2 | USD 73.1 M | Vender |
2,581,469
-482,533
| -16% | -USD 12 M | ﹤0.01% | 1429 |
|
|
2023
Q1 | USD 70.4 M | Vender |
3,064,002
-115,066
| -4% | -USD 3.06 M | ﹤0.01% | 1421 |
|
|
2022
Q4 | USD 89.3 M | Comprar |
3,179,068
+544,296
| +21% | +USD 15.3 M | 0.01% | 1234 |
|
|
2022
Q3 | USD 74.5 M | Vender |
2,634,772
-766,447
| -23% | -USD 20.6 M | ﹤0.01% | 1310 |
|
|
2022
Q2 | USD 75.4 M | Comprar |
3,401,219
+214,706
| +7% | +USD 4.85 M | ﹤0.01% | 1368 |
|
|
2022
Q1 | USD 92.8 M | Comprar |
3,186,513
+193,631
| +6% | +USD 5.92 M | ﹤0.01% | 1343 |
|
|
2021
Q4 | USD 98.4 M | Comprar |
2,992,882
+599,992
| +25% | +USD 24.2 M | ﹤0.01% | 1307 |
|
|
2021
Q3 | USD 110 M | Comprar |
2,392,890
+422,831
| +21% | +USD 20.4 M | 0.01% | 1177 |
|
|
2021
Q2 | USD 109 M | Comprar |
1,970,059
+237,469
| +14% | +USD 13.3 M | 0.01% | 1237 |
|
|
2021
Q1 | USD 89.5 M | Vender |
1,732,590
-889,691
| -34% | -USD 44.1 M | 0.01% | 1316 |
|
|
2020
Q4 | USD 114 M | Comprar |
2,622,281
+555,259
| +27% | +USD 22 M | 0.01% | 1047 |
|
|
2020
Q3 | USD 72.3 M | Comprar |
2,067,022
+172,394
| +9% | +USD 7.56 M | ﹤0.01% | 1179 |
|
|
2020
Q2 | USD 101 M | Vender |
1,894,628
-14,681
| -0.8% | -USD 680 k | 0.01% | 949 |
|
|
2020
Q1 | USD 67.7 M | Comprar |
1,909,309
+24,523
| +1% | +USD 1.13 M | 0.01% | 1061 |
|
|
2019
Q4 | USD 90 M | Comprar |
1,884,786
+33,449
| +2% | +USD 1.26 M | 0.01% | 1114 |
|
|
2019
Q3 | USD 60 M | Comprar |
1,851,337
+104,222
| +6% | +USD 4.31 M | ﹤0.01% | 1317 |
|
|
2019
Q2 | USD 87.1 M | Comprar |
1,747,115
+157,544
| +10% | +USD 8.42 M | 0.01% | 1141 |
|
|
2019
Q1 | USD 107 M | Vender |
1,589,571
-56,357
| -3% | -USD 3.28 M | 0.01% | 962 |
|
|
2018
Q4 | USD 75.9 M | Comprar |
1,645,928
+83,947
| +5% | +USD 5.18 M | 0.01% | 1075 |
|
|
2018
Q3 | USD 120 M | Comprar |
1,561,981
+213,465
| +16% | +USD 17.2 M | 0.01% | 952 |
|
|
2018
Q2 | USD 114 M | Vender |
1,348,516
-140,992
| -9% | -USD 12.3 M | 0.01% | 953 |
|
|
2018
Q1 | USD 122 M | Comprar |
1,489,508
+146,869
| +11% | +USD 11.4 M | 0.01% | 894 |
|
|
2017
Q4 | USD 76.8 M | Comprar |
1,342,639
+86,918
| +7% | +USD 5.47 M | 0.01% | 1172 |
|
|
2017
Q3 | USD 83.8 M | Vender |
1,255,721
-47,245
| -4% | -USD 2.84 M | 0.01% | 1073 |
|
|
2017
Q2 | USD 67 M | Comprar |
1,302,966
+97,220
| +8% | +USD 4.97 M | 0.01% | 1170 |
|
|
2017
Q1 | USD 70.4 M | Vender |
1,205,746
-34,839
| -3% | -USD 1.67 M | 0.01% | 1119 |
|
|
2016
Q4 | USD 51.8 M | Comprar |
1,240,585
+150,244
| +14% | +USD 7.88 M | ﹤0.01% | 1252 |
|
|
2016
Q3 | USD 57.6 M | Comprar |
1,090,341
+191,155
| +21% | +USD 8.32 M | 0.01% | 1148 |
|
|
2016
Q2 | USD 37.7 M | Vender |
899,186
-204,476
| -19% | -USD 10.1 M | ﹤0.01% | 1319 |
|
|
2016
Q1 | USD 44.8 M | Comprar |
1,103,662
+200,468
| +22% | +USD 8.57 M | ﹤0.01% | 1219 |
|
|
2015
Q4 | USD 58.6 M | Comprar |
903,194
+320,847
| +55% | +USD 21 M | 0.01% | 1085 |
|
|
2015
Q3 | USD 41.1 M | Comprar |
582,347
+108,466
| +23% | +USD 10.6 M | ﹤0.01% | 1277 |
|
|
2015
Q2 | USD 52.7 M | Comprar |
473,881
+27,118
| +6% | +USD 2.92 M | 0.01% | 1231 |
|
|
2015
Q1 | USD 42.1 M | Comprar |
446,763
+73,380
| +20% | +USD 8.22 M | ﹤0.01% | 1345 |
|
|
2014
Q4 | USD 41.8 M | Vender |
373,383
-170,801
| -31% | -USD 15.2 M | ﹤0.01% | 1319 |
|
|
2014
Q3 | USD 33.4 M | Comprar |
544,184
+370,286
| +213% | +USD 16 M | ﹤0.01% | 1389 |
|
|
2014
Q2 | USD 7.97 M | Comprar |
173,898
+85,117
| +96% | +USD 3.47 M | ﹤0.01% | 2344 |
|
|
2014
Q1 | USD 3.48 M | Comprar |
88,781
+6,760
| +8% | +USD 226 k | ﹤0.01% | 2779 |
|
|
2013
Q4 | USD 1.96 M | Comprar |
82,021
+25,321
| +45% | +USD 577 k | ﹤0.01% | 3073 |
|
|
2013
Q3 | USD 1.58 M | Comprar |
+56,700
| Nuevas | +USD 1.57 M | ﹤0.01% | 3131 |
|
Otros fondos que tienen AGIO en su cartera
LCM
Posición de State Street en AGIO: resumen de T2 2026
State Street aumentó su participación en Agios Pharmaceuticals (AGIO) en 5% durante T2 2026, al comprar aproximadamente USD 5.12 M y elevar la posición a 3,533,633 acciones con un valor de USD 131 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1324.
State Street reportó por primera vez una posición en AGIO en T3 2013 y la ha mantenido durante 52 trimestres desde entonces. Al cierre de T2 2026, 238 fondos que sigue Wall St. Rank mantienen una posición en AGIO.
- Al cierre de T2 2026, State Street tenía 3,533,633 acciones de Agios Pharmaceuticals con un valor de USD 131 M.
- State Street compró 168,754 acciones de Agios Pharmaceuticals en T2 2026, por un monto estimado de USD 5.12 M.
- Agios Pharmaceuticals representó ﹤0.01% de la cartera de State Street en T2 2026 y fue su posición número 1324.
- State Street reportó por primera vez una posición en Agios Pharmaceuticals en T3 2013 y la ha mantenido durante 52 trimestres desde entonces.
- Al cierre de T2 2026, 238 fondos que sigue Wall St. Rank tenían Agios Pharmaceuticals en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.